{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:14:05Z","timestamp":1783660445508,"version":"3.55.0"},"reference-count":148,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0521405"],"award-info":[{"award-number":["2024ZD0521405"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["GZNL2023A02009"],"award-info":[{"award-number":["GZNL2023A02009"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82474267"],"award-info":[{"award-number":["82474267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Guangdong Province, China","award":["2026B1515020086"],"award-info":[{"award-number":["2026B1515020086"]}]},{"name":"Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine","award":["ZYYCXTD-D-202403"],"award-info":[{"award-number":["ZYYCXTD-D-202403"]}]},{"name":"Innovation and Entrepreneurship Team Introduction Projects of Guangdong Province","award":["2023ZT10Y053"],"award-info":[{"award-number":["2023ZT10Y053"]}]},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome","award":["QZ2023ZZ11"],"award-info":[{"award-number":["QZ2023ZZ11"]}]},{"name":"Chinese Medicine Guangdong Laboratory","award":["HQL2024PZ005"],"award-info":[{"award-number":["HQL2024PZ005"]}]},{"name":"Chinese Medicine Guangdong Laboratory","award":["HQL2025CY007"],"award-info":[{"award-number":["HQL2025CY007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide and is characterized by therapeutic resistance, metabolic plasticity, and immune evasion. Accumulating evidence indicates that metabolic reprogramming not only supports tumor growth but also creates exploitable vulnerabilities linked to regulated cell death. Traditional Chinese medicine (TCM)-derived small molecules have attracted increasing attention owing to their structural diversity, multitarget properties, and broad pharmacological activities. In this review, we summarize recent advances in TCM-derived compounds targeting metabolism-associated regulated cell death in NSCLC, with a primary focus on ferroptosis and a cautious discussion of emerging cuproptosis- and disulfidptosis-related mechanisms. Ferroptosis has been extensively investigated in this context, with natural compounds shown to induce cell death through coordinated regulation of cystine transport, glutathione metabolism, GPX4 activity, iron homeostasis, and lipid peroxidation. In parallel, emerging studies suggest that certain natural products may influence copper-dependent cell death pathways and metabolic states associated with disulfide stress. These processes are closely linked to distinct metabolic features of NSCLC, including lipid dependency, copper homeostasis, and glucose utilization. Finally, we discuss major challenges for clinical translation, including poor bioavailability, off-target toxicity, insufficient biomarker stratification, and limited high-quality evidence, and highlight emerging strategies such as nanodelivery systems, structural optimization, and targeted protein degradation approaches. Overall, TCM-derived small molecules represent a promising source of metabolism-targeted therapeutics and provide a foundation for further exploration of regulated cell death in NSCLC. Current evidence is strongest for ferroptosis induction, whereas cuproptosis- and disulfidptosis-related mechanisms remain emerging areas that require further experimental validation in NSCLC models.<\/jats:p>","DOI":"10.3390\/ph19071026","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:50:37Z","timestamp":1782867037000},"page":"1026","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TCM-Derived Small Molecules Targeting Metabolic Vulnerabilities in NSCLC: Ferroptosis-Centered Mechanisms and Emerging Cuproptosis- and Disulfidptosis-Related Vulnerabilities"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9152-0225","authenticated-orcid":false,"given":"Haiyi","family":"Zhang","sequence":"first","affiliation":[{"name":"Chinese Medicine Guangdong Laboratory, Guangzhou University of Chinese Medicine, Zhuhai 519000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Chinese Medicine Guangdong Laboratory, Guangzhou University of Chinese Medicine, Zhuhai 519000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[{"name":"Chinese Medicine Guangdong Laboratory, Guangzhou University of Chinese Medicine, Zhuhai 519000, China"},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Chinese Medicine Guangdong Laboratory, Guangzhou University of Chinese Medicine, Zhuhai 519000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-1595","authenticated-orcid":false,"given":"Runze","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Medicine Guangdong Laboratory, Guangzhou University of Chinese Medicine, Zhuhai 519000, China"},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann. Glob. Health"},{"key":"ref_2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003\u201315: A pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"ref_6","first-page":"1","article-title":"An overview of chemotoxicity and radiation toxicity in cancer therapy","volume":"155","author":"Yazbeck","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imr.13274","article-title":"Targeted therapy for non-small-cell lung cancer: New insights into regulated cell death combined with immunotherapy","volume":"321","author":"Li","year":"2024","journal-title":"Immunol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1002\/mco2.693","article-title":"Cell death pathways: Molecular mechanisms and therapeutic targets for cancer","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.20517\/cdr.2023.78","article-title":"Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance","volume":"6","author":"Chen","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.70045","article-title":"Molecular mediators of metabolic reprogramming in cancer: Mechanisms, regulatory networks, and therapeutic strategies","volume":"177","author":"Ahuja","year":"2026","journal-title":"Immunology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/procel\/pwae003","article-title":"Metabolic cell death in cancer: Ferroptosis, cuproptosis, disulfidptosis, and beyond","volume":"15","author":"Mao","year":"2024","journal-title":"Protein Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41568-025-00879-8","article-title":"Exploiting metabolic cell death for cancer therapy","volume":"26","author":"Mao","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: Recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fan, M., Jin, C., Li, D., Deng, Y., Yao, L., Chen, Y., Ma, Y.-L., and Wang, T. (2023). Multi-level advances in databases related to systems pharmacology in traditional Chinese medicine: A 60-year review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1289901"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e33934","DOI":"10.1016\/j.heliyon.2024.e33934","article-title":"Targeting ferroptosis regulators in lung cancer: Exploring natural products","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yao, J., Ma, C., Feng, K., Tan, G., and Wen, Q. (2022). Focusing on the role of natural products in overcoming cancer drug resistance: An autophagy-based perspective. Biomolecules, 12.","DOI":"10.3390\/biom12111565"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","article-title":"Ferroptosis: A cell death connecting oxidative stress, inflammation and cardiovascular diseases","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: Mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ge, C., Zhang, S., Mu, H., Zheng, S., Tan, Z., Huang, X., Xu, C., Zou, J., Zhu, Y., and Feng, D. (2022). Emerging mechanisms and disease implications of ferroptosis: Potential applications of natural products. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.774957"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41571-026-01128-z","article-title":"Translating ferroptosis into oncology: Challenges, opportunities and future directions","volume":"23","author":"Kang","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Jin, J., Hu, J., Li, M., Gu, W., Jiang, X., and Stockwell, B.R. (2026). Ferroptosis as an approach to leverage cancer metabolism. Trends Cell Biol., in press.","DOI":"10.1016\/j.tcb.2026.03.008"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chen, X., Cui, H., Qin, L., Liu, R., Fang, F., and Wang, Z. (2025). Soybean Lecithin\u2013Gallic Acid Complex Sensitizes Lung Cancer Cells to Radiation Through Ferroptosis Regulated by Nrf2\/SLC7A11\/GPX4 Pathway. Nutrients, 17.","DOI":"10.3390\/nu17071262"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature24637","article-title":"NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis","volume":"551","author":"Alvarez","year":"2017","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Qiu, J., Wu, R., Long, Y., Peng, L., Yang, T., Zhang, B., Shi, X., Liu, J., and Zhang, X. (2022). Role of Fe, transferrin and transferrin receptor in anti-tumor effect of vitamin C. Cancers, 14.","DOI":"10.3390\/cancers14184507"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: More ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mortensen, M.S., Ruiz, J., and Watts, J.L. (2023). Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells, 12.","DOI":"10.3390\/cells12050804"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Yang, Y., Zhu, T., Wang, X., Xiong, F., Hu, Z., Qiao, X., Yuan, X., and Wang, D. (2022). ACSL3 and ACSL4, distinct roles in ferroptosis and cancers. Cancers, 14.","DOI":"10.3390\/cancers14235896"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","article-title":"FSP1: A key regulator of ferroptosis","volume":"29","author":"Li","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s12035-023-03646-8","article-title":"Oxytosis\/ferroptosis in neurodegeneration: The underlying role of master regulator glutathione peroxidase 4 (GPX4)","volume":"61","author":"Dar","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"123612","DOI":"10.1016\/j.lfs.2025.123612","article-title":"Targeting vulnerability in tumor therapy: Dihydroorotate dehydrogenase","volume":"371","author":"Lin","year":"2025","journal-title":"Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","volume":"649","author":"Wu","year":"2026","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jare.2023.08.018","article-title":"\u03b2-Elemene induced ferroptosis via TFEB-mediated GPX4 degradation in EGFR wide-type non-small cell lung cancer","volume":"62","author":"Zhao","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"106739","DOI":"10.1016\/j.phrs.2023.106739","article-title":"\u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer","volume":"191","author":"Xu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12935-025-03925-5","article-title":"Periplocin potentiates ferroptotic cell death in non-small cell lung cancer by inducing the degradation of Nrf2","volume":"25","author":"Wang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Li, L., Gao, Q., Wang, J., Gu, L., Li, Z., Zhang, S., Hu, C., He, M., Wang, Y., and Wang, Z. (2022). Induction of ferroptosis by ophiopogonin-B through regulating the gene signature AURKA in NSCLC. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.833814"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, X., and Li, J. (2024). Ferroptosis in lung cancer: Dual role, multi-level regulation, and new therapeutic strategies. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1360638"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.7150\/jca.57054","article-title":"Artemisinin derivatives inhibit non-small cell lung cancer cells through induction of ROS-dependent apoptosis\/ferroptosis","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis","volume":"27","author":"Chen","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"176805","DOI":"10.1016\/j.ejphar.2024.176805","article-title":"Cucurbitacin B targets STAT3 to induce ferroptosis in non-small cell lung cancer","volume":"978","author":"Zeng","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"110588","DOI":"10.1016\/j.cbi.2023.110588","article-title":"Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation","volume":"382","author":"Qian","year":"2023","journal-title":"Chem.-Biol. Interact."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2527752","DOI":"10.1080\/10717544.2025.2527752","article-title":"Nanomedicine initiates ferroptosis for enhanced lung cancer therapy","volume":"32","author":"Xu","year":"2025","journal-title":"Drug Deliv."},{"key":"ref_60","first-page":"159560","article-title":"Spermidine mitigates ferroptosis in free fatty acid-induced AML-12 cells through the ATF4\/SLC7A11\/GCLM\/GPX4 pathway","volume":"1869","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) \u2014Mol. Cell Biol. Lipids"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"Ren","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105038","DOI":"10.1016\/j.tiv.2020.105038","article-title":"Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells","volume":"70","author":"Fouzder","year":"2021","journal-title":"Toxicol. Vitr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2174\/1389201023666211217151955","article-title":"Oridonin induces oxidative stress-mediated cancer cells apoptosis via targeting thioredoxin reductase","volume":"23","author":"Duan","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: When metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yang, J., Chen, C., Li, Z., Chen, Y., Zhang, X., Wang, L., and Zhou, J. (2021). Polyphyllin III-Induced ferroptosis in MDA-MB-231 triple-negative breast cancer cells can Be protected against by KLF4-mediated upregulation of xCT. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.670224"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/ars.2023.0237","article-title":"LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity","volume":"39","author":"Cui","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3892\/or.2024.8782","article-title":"Natural products targeting ferroptosis pathways in cancer therapy","volume":"52","author":"Na","year":"2024","journal-title":"Oncol. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Gao, G., and Zhang, X. (2025). Broadening horizons: Research on ferroptosis in lung cancer and its potential therapeutic targets. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1542844"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4149\/neo_2022_211103N1568","article-title":"Co-treatment of betulin and gefitinib is effective against EGFR wild-type\/KRAS-mutant non-small cell lung cancer by inducing ferroptosis","volume":"69","author":"Yan","year":"2022","journal-title":"Neoplasma"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","article-title":"The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12935-025-03864-1","article-title":"Cuproptosis: A novel therapeutic mechanism in lung cancer","volume":"25","author":"Luo","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","article-title":"The molecular mechanisms of copper metabolism and its roles in human diseases","volume":"472","author":"Chen","year":"2020","journal-title":"Pfl\u00fcgers Arch.-Eur. J. Physiol."},{"key":"ref_74","first-page":"880","article-title":"The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases","volume":"24","author":"Jomova","year":"2025","journal-title":"EXCLI J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ila2.22","article-title":"The mechanism of copper homeostasis and its role in disease","volume":"1","author":"Li","year":"2023","journal-title":"Ilabmed"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"215793","DOI":"10.1016\/j.canlet.2022.215793","article-title":"Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC","volume":"543","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1038\/s41467-024-50524-5","article-title":"PTPN2 copper-sensing relays copper level fluctuations into EGFR\/CREB activation and associated CTR1 transcriptional repression","volume":"15","author":"Ross","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lungcan.2011.06.011","article-title":"Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy","volume":"75","author":"Chen","year":"2012","journal-title":"Lung Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Georgiou-Siafis, S.K., and Tsiftsoglou, A.S. (2023). The key role of GSH in keeping the redox balance in mammalian cells: Mechanisms and significance of GSH in detoxification via formation of conjugates. Antioxidants, 12.","DOI":"10.3390\/antiox12111953"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Tsymbal, S., Refeld, A., Zatsepin, V., and Kuchur, O. (2023). The p53 protein is a suppressor of Atox1 copper chaperon in tumor cells under genotoxic effects. PLoS ONE, 18.","DOI":"10.1101\/2023.07.25.550476"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zhou, Y., and Zhang, L. (2023). The interplay between copper metabolism and microbes: In perspective of host copper-dependent ATPases ATP7A\/B. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1267931"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/iub.1722","article-title":"Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy","volume":"70","author":"Li","year":"2018","journal-title":"IUBMB Life"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","article-title":"Elesclomol: A copper ionophore targeting mitochondrial metabolism for cancer therapy","volume":"41","author":"Zheng","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41467-025-67869-0","article-title":"Deep Mutational Scanning of FDX1 Identifies Key Structural Determinants of Lipoylation and Cuproptosis","volume":"17","author":"Hsiao","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","article-title":"Protein lipoylation: Mitochondria, cuproptosis, and beyond","volume":"49","author":"Lin","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","article-title":"Cuproptosis: Lipoylated TCA cycle proteins-mediated novel cell death pathway","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","article-title":"Cuproptosis: A new form of programmed cell death","volume":"19","author":"Wang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41420-025-02718-z","article-title":"Protein lipoylation in cancer: Metabolic reprogramming and therapeutic potential","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12943-025-02472-x","article-title":"Targeting proteostasis for cancer therapy: Current advances, challenges, and future perspectives","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"114165","DOI":"10.1016\/j.intimp.2025.114165","article-title":"SRF\/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC","volume":"148","author":"Xue","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12967-022-03741-9","article-title":"Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Qin, X., Wang, P., Liang, H., and Si, W. (2024). Curcumin suppresses copper accumulation in non-small cell lung cancer by binding ATOX1. BMC Pharmacol. Toxicol., 25.","DOI":"10.1186\/s40360-024-00784-0"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kumar, A., Corey, C., Scott, I., Shiva, S., and D\u2019Cunha, J. (2016). Minnelide\/Triptolide impairs mitochondrial function by regulating SIRT3 in P53-dependent manner in non-small cell lung cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160783"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1021\/np200029q","article-title":"Gambogic acid, a natural product inhibitor of Hsp90","volume":"74","author":"Davenport","year":"2011","journal-title":"J. Nat. Prod."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/CAD.0000000000000140","article-title":"Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration","volume":"25","author":"Zismanov","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","article-title":"xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression","volume":"37","author":"Ji","year":"2018","journal-title":"Oncogene"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12964-024-01871-9","article-title":"Disulfidptosis: A novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"102649","DOI":"10.1016\/j.isci.2021.102649","article-title":"KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition","volume":"24","author":"Koppula","year":"2021","journal-title":"iScience"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14348\/molcells.2023.0060","article-title":"Disulfidptosis: Disulfide stress mediates a novel cell death pathway via actin cytoskeletal vulnerability","volume":"46","author":"Shao","year":"2023","journal-title":"Mol. Cells"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.7150\/jca.30772","article-title":"Glucose transporter 1 promotes the malignant phenotype of non-small cell lung cancer through integrin \u03b21\/Src\/FAK signaling","volume":"10","author":"Zhao","year":"2019","journal-title":"J. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"32667","DOI":"10.18632\/oncotarget.25994","article-title":"Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells","volume":"9","author":"Suzuki","year":"2018","journal-title":"Oncotarget"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2018.12.006","article-title":"The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis","volume":"689","author":"Zhang","year":"2019","journal-title":"Gene"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"15503","DOI":"10.1038\/ncomms15503","article-title":"The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition","volume":"8","author":"Goodwin","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"R241","DOI":"10.1016\/j.cub.2025.02.042","article-title":"Disulfidptosis","volume":"35","author":"Li","year":"2025","journal-title":"Curr. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7150\/ijbs.31749","article-title":"Repression of hexokinases II-mediated glycolysis contributes to piperlongumine-induced tumor suppression in non-small cell lung cancer cells","volume":"15","author":"Zhou","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2147\/OTT.S243212","article-title":"Sinomenine inhibits non-small cell lung cancer via downregulation of hexokinases II-mediated aerobic glycolysis","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_107","first-page":"1","article-title":"Apigenin Inhibits Glycolysis and Spheroid Formation via Downregulation of HK-2 Expression in Non-Small Cell Lung Cancer H460 Cells","volume":"20","author":"Sun","year":"2023","journal-title":"J. Hunan Norm. Univ. (Med. Sci.)"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41419-023-06142-y","article-title":"Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41401-024-01353-1","article-title":"Overview and limitations of database in global traditional medicines: A narrative review","volume":"46","author":"Li","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"24515","DOI":"10.1038\/s41598-025-08665-0","article-title":"Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Bu\u010devi\u0107 Popovi\u0107, V., Karahmet Farhat, E., Banjari, I., Jeli\u010di\u0107 Kadi\u0107, A., and Puljak, L. (2024). Bioavailability of oral curcumin in systematic reviews: A methodological study. Pharmaceuticals, 17.","DOI":"10.3390\/ph17020164"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Bertoncini-Silva, C., Vlad, A., Ricciarelli, R., Giacomo Fassini, P., Suen, V.M.M., and Zingg, J.-M. (2024). Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment. Antioxidants, 13.","DOI":"10.3390\/antiox13030331"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Nowacka, A., \u015aniegocka, M., Smuczy\u0144ski, W., Liss, S., Zi\u00f3\u0142kowska, E., Bo\u017ci\u0142ow, D., \u015aniegocki, M., and Wici\u0144ski, M. (2024). The potential application of resveratrol and its derivatives in central nervous system tumors. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413338"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Solnier, J., Zhang, Y., Kuo, Y.C., Du, M., Roh, K., Gahler, R., Wood, S., and Chang, C. (2023). Characterization and pharmacokinetic assessment of a new berberine formulation with enhanced absorption in vitro and in human volunteers. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112567"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Mirza, M.A., Mahmood, S., Hilles, A.R., Ali, A., Khan, M.Z., Zaidi, S.A.A., Iqbal, Z., and Ge, Y. (2023). Quercetin as a therapeutic product: Evaluation of its pharmacological action and clinical applications\u2014A review. Pharmaceuticals, 16.","DOI":"10.3390\/ph16111631"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1142\/S0192415X26500072","article-title":"Molecular Mechanisms and Therapeutic Potentials of Triptolide in Autoimmune Diseases: Advances and Challenges","volume":"54","author":"Zhang","year":"2026","journal-title":"Am. J. Chin. Med."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yang, B., Dong, Y., Wang, F., and Zhang, Y. (2020). Nanoformulations to enhance the bioavailability and physiological functions of polyphenols. Molecules, 25.","DOI":"10.3390\/molecules25204613"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Lu, H., Zhang, S., Wang, J., and Chen, Q. (2021). A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.783831"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.foodchem.2013.12.067","article-title":"Curcumin\u2013\u03b2-cyclodextrin inclusion complex: Stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application","volume":"153","author":"Mangolim","year":"2014","journal-title":"Food Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00394-016-1376-9","article-title":"Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects","volume":"57","author":"Purpura","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13318-018-0517-3","article-title":"Improved oral absorption of quercetin from quercetin phytosome\u00ae, a new delivery system based on food grade lecithin","volume":"44","author":"Riva","year":"2018","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","article-title":"Abraxane\u00ae, a novel Cremophor\u00ae-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer","volume":"17","author":"Green","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/17435889.2.4.415","article-title":"Nanoparticle albumin-bound paclitaxel: A novel Cremphor-EL\u00ae-free formulation of paclitaxel","volume":"2","author":"Stinchcombe","year":"2007","journal-title":"Nanomedicine"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/cas.15377","article-title":"Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs","volume":"113","author":"Milano","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_125","first-page":"000191","article-title":"Recent approaches of impurity profiling in pharmaceutical analysis: A concise review","volume":"8","author":"Bachhav","year":"2024","journal-title":"Med. Analy Chem. Int. J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/10408347.2024.2305267","article-title":"Quality consistency evaluation of traditional Chinese medicines: Current status and future perspectives","volume":"55","author":"Liu","year":"2025","journal-title":"Crit. Rev. Anal. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1021\/acs.jmedchem.3c02239","article-title":"Chirality of new drug approvals (2013\u20132022): Trends and perspectives","volume":"67","author":"McVicker","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Noviana, E., Indrayanto, G., and Rohman, A. (2022). Advances in fingerprint analysis for standardization and quality control of herbal medicines. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.853023"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Tran, K.N., Mac, G.L., Munni, Y.A., and Yang, I.-J. (2025). Q-marker identification strategies in traditional Chinese medicines: A systematic review of research from 2020 to 2024. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1709969"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: Molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.jnatprod.9b00949","article-title":"Scientific and regulatory approach to botanical drug development: A US FDA perspective","volume":"83","author":"Wu","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s43441-025-00786-y","article-title":"Analysis of Regulatory Botanical Submission Profile for Cancer Management from the US FDA Perspectives","volume":"59","author":"Park","year":"2025","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., and Wang, C. (2023). Advancing herbal medicine: Enhancing product quality and safety through robust quality control practices. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1265178"},{"key":"ref_134","unstructured":"U.S. Food and Drug Administration (2016). Botanical Drug Development: Guidance for Industry."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.apsb.2020.08.003","article-title":"Botanical drug clinical trial: Common issues and future options","volume":"11","author":"Sun","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Guan, S., Tu, M.-J., and Yu, A.-M. (2025). Practical Pharmacokinetic\u2013Pharmacodynamic Models in Oncology. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17111452"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1445826","DOI":"10.3389\/or.2024.1445826","article-title":"Biomarker testing in lung cancer: From bench to bedside","volume":"18","author":"Batra","year":"2025","journal-title":"Oncol. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e19332","DOI":"10.7717\/peerj.19332","article-title":"Research progress of nano drug delivery systems in the anti-tumor treatment of traditional Chinese medicine monomers","volume":"13","author":"Song","year":"2025","journal-title":"PeerJ"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"107201","DOI":"10.1016\/j.fitote.2026.107201","article-title":"Natural product PROTACylation: Development of Maslinic acid-based JAK2 degraders for cancer therapy","volume":"190","author":"Zhang","year":"2026","journal-title":"Fitoterapia"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e27321","DOI":"10.1002\/adfm.202527321","article-title":"Tumor Microenvironment-Responsive PROTAC Prodrugs: A Pioneering Strategy for Precision Cancer Therapy","volume":"36","author":"Yao","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Lei, Y., Jiang, S., Kong, C., Pang, P., and Shan, H. (2025). Ferroptosis: Therapeutic potential and strategies in non-small cell lung cancer. Biology, 14.","DOI":"10.3390\/biology14050545"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-023-06070-x","article-title":"FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and-independent manner","volume":"14","author":"Kim","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s43556-025-00340-0","article-title":"Multi-omics strategies for biomarker discovery and application in personalized oncology","volume":"6","author":"Jiang","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2021.06.051","article-title":"Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells","volume":"567","author":"Ni","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Li, F.-J., Long, H.-Z., Zhou, Z.-W., Luo, H.-Y., Xu, S.-G., and Gao, L.-C. (2022). System Xc\u2212\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.910292"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/1026\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:30:56Z","timestamp":1783657856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/1026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":148,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ph19071026"],"URL":"https:\/\/doi.org\/10.3390\/ph19071026","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}